JIANGSU HENGRUI MEDICINE CO., LTD.
Patent Owner
Stats
- 31 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 31 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 236 Total Citation Count
- Sep 16, 2002 Earliest Filing
- 12 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0313,709 CRYSTALLINE FORM OF JAK KINASE INHIBITOR BISULFATE AND A PREPARATION METHOD THEREOFOct 09, 15Nov 02, 17[C07D]
2017/0189,392 LIPOSOME OF IRINOTECAN OR IRINOTECAN HYDROCHLORIDE AND PREPARATION METHOD THEREOFMar 21, 17Jul 06, 17[A61K]
2016/0326,230 HUMAN RELAXIN ANALOGUE, PHARMACEUTICAL COMPOSITION OF SAME, AND PHARMACEUTICAL APPLICATION OF SAMEOct 10, 14Nov 10, 16[A61K, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9914703 Pyridic ketone derivatives, method of preparing same, and pharmaceutical application thereofSep 05, 14Mar 13, 18[A61K, C07D]
9895355 Methods of treating androgen receptor-mediated disorders with imidazoline derivativesJan 20, 17Feb 20, 18[A61K]
9637484 Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereofApr 29, 14May 02, 17[A61K, C07D, C07C]
9586947 Imidazoline derivatives, preparation methods thereof, and their applications in medicineAug 26, 13Mar 07, 17[C07D]
9527851 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereofDec 19, 12Dec 27, 16[A61K, C07D, A61P]
9422300 Bisulfate of janus kinase (JAK) inhibitor and preparation method thereforMay 05, 14Aug 23, 16[C07D]
9358227 Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivativesDec 01, 14Jun 07, 16[A61K, C07F, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8618104 Salts of methyl (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-A]pyrazine-1-carboxylateExpiredApr 29, 10Dec 31, 13[A61K, A61P]
2013/0338,190 PHARMACEUTICALLY ACCEPTABLE SALT OF (E)-N-[4-[[3-CHLORO-4-(2-PYRIDYLMETHOXY)PHENYL]AMINO]-3-CYANO-7-ETHOXY-6-QUINOLYL]-3-[(2R)-1-METHYLPYRROLIDIN-2-YL]PROP-2-ENAMIDE, PREPARATION METHOD THEREOF, AND MEDICAL USE THEREOFAbandonedFeb 10, 12Dec 19, 13[C07D, C07C]
2013/0123,507 BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOFAbandonedJan 16, 13May 16, 13[C07D]
2012/0295,887 PHARMACEUTICALLY ACCEPTABLE SALTS OF PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND MEDICAL USE THEREOFAbandonedJan 07, 11Nov 22, 12[A61K, C07D, A61P]
2012/0282,325 LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOFAbandonedDec 03, 09Nov 08, 12[A61K, A61P]
8299069 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihydro-1H-pyrrol[3,2-C]pyridine-4(5H)-one compounds and use as protein kinase inhibitorsExpiredJul 29, 08Oct 30, 12[A61K, C07D]
2012/0045,489 Nano-Emulsion Injection of Vinca Alkaloids and the Preparation Method ThereofAbandonedDec 08, 09Feb 23, 12[A61K, B82Y, A61P]
2011/0026,457 SYSTEM FOR USING INTERNET TELEPHONE WITH MOBILE AND METHOD THEREOFAbandonedAug 07, 08Feb 03, 11[H04L, H04W]
2010/0218,762 METHOD FOR STORING THE INHALATION ANESTHETIC AND CONTAINER THEREOFAbandonedOct 15, 08Sep 02, 10[B65D, A61M]
2010/0210,640 BENZAMIDE DERIVATIVES, THEIR PREPARATION AND USES IN MEDICINE THEREOFAbandonedSep 01, 08Aug 19, 10[A61K, C07D, A61P]
6960611 Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereofExpiredSep 16, 02Nov 01, 05[C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.